News Release

Blade expands organ air mobility footprint with 14 new transplant centres in 2022; MediMobility division now operating in 20 states

Blade Air Mobility, the US technology-powered air mobility platform, today announced an expansion of the operating footprint for its organ transportation business. With the addition of 14 transplant centres and Organ Procurement Organizations (OPOs) during 2022, Blade's MediMobility division now serves more than 40 hospital clients across 20 US states.

Scott Wunsch, COO of Blade MediMobility said, "Our expanded footprint provides immediate benefits for all of the transplant centres and OPOs we serve. By leveraging the growing buying power of both Blade's individual consumer fliers and hospital clients, we have secured dedicated access to more aircraft in more locations at very favourable rates. Additionally, we can now offer standby access to aircraft in new geographies, enabling unprecedented flexibility to pursue organs that might otherwise go unused. This is a significant value add to our clients, especially given tight availability of certain types of charter aircraft currently."

"Our integrated, multimodal offering enables transplant programmes to reduce organ transport time and cost, resulting in improved patient and programme outcomes. Blade's last-mile offering, currently serviced by captive helicopters and ambulances, continues to expand with these new hospital additions,” said Will Heyburn, CFO of Blade. “We are leveraging our unmatched scale in critical last-mile delivery to push towards a transition to drones and electric vertical aircraft or EVA, enabling further reduced transport time and cost.”

Mr. Heyburn added, “Given the existing on-site landing pad infrastructure at most of our client hospitals as well as our EVA manufacturer partnerships, we believe our MediMobility division is well positioned to utilise these new aircraft as soon as they are available for commercial use, reducing our hospital partners' need for intermodal ground transport.”